Vivo Capital related stories
All articles and analysis
VC-backed AirXpanders snags $7 mln from GE CapitalAirXpanders has received a $7 million credit facility from GE Capital. Based in Palo Alto, Calif., AirXpanders is a tissue-expansion company focused on breast cancer reconstruction. It is backed by Vivo Ventures, GBS Venture Partners, Prolog Ventures, Heron Capital and Shalon Ventures.
- Aclaris Therapeutics Closes $21M Series A
Aclaris Therapeutics Inc., a specialty pharmaceutical company focused on dermatology, has raised $21 million. The Series A was led by Vivo Ventures and Fidelity Biosciences with participation from Sofinnova Ventures. The money will be used for product development.
- Fundraising Revives for Health Care VCs
Prospects look sunnier, as new funds are raised some healthy exits take place
- Venture Fundraising Roundup, February 2012
Updates on First Round, Vivo Ventures, Hyde Park and other VC firms
- Allergan Buys Vicept Therapeutics
Allergan is buying privately held dermatology company Vicept Therapeutics. Formed in 2009, Vicept is backed by investors including Vivo Ventures, Fidelity Biosciences and Sofinnova Ventures. Under the terms of the acquisition, which is expected to close during the third quarter, Allergan will pay $75 million in cash up-front, as well as up to $200 million in payments tied to specific milestones.